Triumeq - Treatment Option for HIV-1 Infection in All Age Groups
Triumeq FAQ
How does Triumeq work?
1. How it works Triumeq is a fixed-dose combination tablet that contains three antivirals: abacavir, dolutegravir, and lamivudine, which may be used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and children weighing at least 10 kg (22 pounds). Each component of Triumeq works differently.
Is Triumeq a prescription drug?
Triumeq and Triumeq PD are prescription medicines approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children. Triumeq is approved for use in adults and children who weigh at least 55 lb (25 kg). Triumeq PD is approved for use in children who weigh 22 lb (10 kg) to less than 55 lb (25 kg).
What information can I find about Triumeq?
Please refer to our terms and conditions. On this page about Triumeq you will find information relating to side effects, age restrictions, food interactions, whether the medicine is available at a government subsidised price on the pharmaceutical benefits scheme (PBS) as well as other useful information.
Who should use Triumeq?
package leaflet (annex IIIB). Triumeq is indicated for the treatment of Human Immunodeficiency Virus (HIV) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with HIV without documented or clinically suspected resistance to any of the three antiretroviral agents in Triumeq.
What is Triumeq?
TRIUMEQ is a pill and contains abacavir, dolutegravir, and lamivudine. TRIUMEQ is also available as tablets for oral suspension: TRIUMEQ PD. View the Patient Information with Important Warnings. Learn more about TRIUMEQ (abacavir, dolutegravir, and lamivudine). See Full Safety and Prescribing Info, including Boxed Warning.
Is Triumeq a single-component medicine?
All three active substances in Triumeq are already available in the EU as single-component medicines: abacavir has been authorised as Ziagen since 1999, lamivudine as Epivir since 1996, and dolutegravir as Tivicay since 2014. The combination of abacavir and lamivudine has been authorised as Kivexa since 2004.
Does Triumeq work for HIV?
HIV is a virus that attacks your immune system, which is your body’s defense against infection. Another version of Triumeq, called Triumeq PD, is available to treat HIV in children who weigh from 10 kg (about 22 lb) to less than 25 kg (about 55 lb). Triumeq and Triumeq PD have certain limitations of use.
Who can use Triumeq PD?
For this purpose, Triumeq is approved for use in adults as well as children who weigh 25 kilograms (kg) or more (about 55 pounds [lb] or more). Triumeq PD is approved for use in children who weigh from 10 kg (about 22 lb) to less than 25 kg (about 55 lb).
Triumeq References
If you want to know more about Triumeq, consider exploring links below:
What Is Triumeq
- https://www.drugs.com/triumeq.html
- https://www.healthline.com/health/drugs/triumeq
- https://www.healthdirect.gov.au/medicines/brand/amt,691311000168105/triumeq
- https://www.medicalnewstoday.com/articles/triumeq
- https://medsinfo.com.au/consumer-information/document/Triumeq_CMI
- https://us.triumeq.com/
- https://www.aidsmap.com/about-hiv/arv-factsheet/triumeq
- https://clinicalinfo.hiv.gov/en/drugs/abacavir-dolutegravir-lamivudine/patient
- https://www.ema.europa.eu/en/medicines/human/EPAR/triumeq